Patents Examined by Gail E. Poulos
  • Patent number: 5126253
    Abstract: A novel cell line for use as a parent for hybridoma preparation is provided. This cell line is derived from tumor cells, in particular human tumor cells, other than those originating from bone marrow cells. A method for establishing this cell line is also provided. By fusing this cell line with cells producing useful physiologically active substances, such as B cells immunized with an antigen, a hybridoma capable of active growth can be prepared. This hybridoma can be cultivated for the production of useful physiologically active substances.
    Type: Grant
    Filed: September 25, 1986
    Date of Patent: June 30, 1992
    Assignee: Suntory Limited
    Inventors: Toshihiro Nakanishi, Masashi Matsui, Kenju Miura, Yoshiaki Fukuda, Teruhisa Noguchi
  • Patent number: 4952506
    Abstract: Nonanchorage-dependent cells are immobilized for cell culturing or the production of cell products, by contracting an aqueous suspension of the cells with a floc formed by the combination of positively and negatively charged ion exchange resins having particle sizes ranging from about 0.01 to about 1.5 microns. The flocs may be formed either prior to contract with the cells or may be formed in situ in the cell suspension upon separate addition of the resins, preferably by first adding the positively charged resin followed by the negatively charged resin. The resin floc operates as a microcarrier for the cells.
    Type: Grant
    Filed: April 28, 1986
    Date of Patent: August 28, 1990
    Assignee: Rohm and Haas Company
    Inventors: Michael J. Byers, Eric G. Isacoff, John O. Naples
  • Patent number: 4918011
    Abstract: 3',4'-anhydrovinblastine, a precursor of the anti-tumor alkaloids vincristine and vinblastine, is prepared by the enzymatic coupling of catharanthine and vindoline using an iron-containing compound such as peroxidase optionally in the presence of a peroxide. Substantially enhanced yields are obtained.
    Type: Grant
    Filed: August 4, 1986
    Date of Patent: April 17, 1990
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Anne E. Goodbody, Endo Tsuyoshi, John Vukovic, Masanaru Misawa